Blood Tests for Leukemia in Children
For suspected pediatric leukemia, obtain a complete blood count (CBC) with differential and peripheral blood smear as the essential initial blood tests, followed immediately by comprehensive metabolic panel, lactate dehydrogenase (LDH), uric acid, phosphate, and coagulation studies (PT, PTT, fibrinogen) to assess for tumor lysis syndrome and disseminated intravascular coagulation. 1
Initial Required Blood Tests
The diagnostic workup begins with routine laboratory tests on peripheral blood 1:
- CBC with differential count and peripheral blood smear review - This is mandatory for all suspected cases 1
- Comprehensive metabolic panel - Critical for monitoring tumor lysis syndrome, particularly in B-lymphoblastic lymphoma 1
- LDH, uric acid, and phosphate levels - Essential markers of tumor burden and lysis 1
- Coagulation panel (PT, PTT, fibrinogen) - Required to detect early disseminated intravascular coagulation, especially if acute promyelocytic leukemia is suspected 1
Key Clinical Indicators from Blood Tests
Red flags in initial blood work that strongly suggest leukemia 2, 3:
- Hemoglobin < 8.5 g/dL (highly predictive)
- Platelet count < 150,000/μL (highly predictive)
- White blood cell count patterns (though can be normal in up to 35% of cases initially) 4
- Elevated LDH > 400 U/L (particularly concerning for neuroblastoma differential) 2
Important caveat: Approximately one-third of pediatric ALL patients present with completely normal CBC at initial presentation 4. Therefore, normal blood counts should never delay oncologic assessment when clinical presentation is suspicious (persistent bone pain, unexplained constitutional symptoms, organomegaly).
Advanced Blood Testing When Peripheral Blood Shows Blasts
If sufficient blasts are present in peripheral blood, the following can be performed directly on blood samples, potentially avoiding immediate bone marrow biopsy 1:
Flow Cytometry Immunophenotyping
- Multicolor comprehensive flow cytometry panel covering B-ALL, T-ALL, AML, and mixed phenotype acute leukemia (MPAL) 1
- Peripheral blood flow cytometry has >98% accuracy for pediatric leukemia diagnosis 5
- Critical exceptions requiring bone marrow confirmation: suspected early T-cell precursor ALL (ETP-ALL), MPAL, and acute megakaryoblastic leukemia (AMKL) - these can show discrepant immunophenotypes between peripheral blood and bone marrow 5
Molecular and Cytogenetic Studies
When peripheral blood contains adequate blasts 1:
- FISH studies for specific translocations
- Molecular studies (RT-PCR) for fusion transcripts and mutations
- Conventional karyotyping (though bone marrow remains preferred)
Specific Testing by Leukemia Subtype
For Childhood ALL (when diagnosed) 1:
Blood-based molecular studies include:
- RT-PCR for PAX-5, JAK1, JAK2, IKZF1 (B-ALL)
- BCR-ABL1 fusion products
- CRLF2 overexpression (B-ALL)
- NOTCH1 and/or FBXW7 (T-ALL)
For Childhood AML (when diagnosed) 1:
Blood-based molecular studies include:
- FLT3-ITD, IDH1, IDH2, TET2, WT1, DNMT3A, TP53
- NPM1, KIT, CEBPA, RUNX1
- PML-RARA (if acute promyelocytic leukemia suspected)
- DIC profile mandatory if APL suspected 1
Distinguishing Leukemia from Leukemoid Reaction
Factors favoring leukemia over leukemoid reaction when WBC >50,000/μL 3:
- Age ≥2 years
- No known underlying disease
- WBC ≥60,555/μL
- Platelet count <118,000/μL
- LDH ≥781 U/L
- CRP <0.91 mg/dL
Critical Timing Considerations
The mean time from symptom onset to diagnosis can be 20-40 days 4. When clinical suspicion is high (persistent bone pain, constitutional symptoms, organomegaly), do not wait for hematologic abnormalities to develop - proceed directly to bone marrow examination even with normal peripheral blood counts 4.
Early immunophenotyping can detect disease before morphologic criteria are met: CD10+/TdT+ cells exceeding 10% in bone marrow or 0.03% in peripheral blood strongly suggests smoldering ALL, even when morphology appears normal 6.